[1]王睿琪,张晓东,田 耘.肾复康Ⅱ号胶囊对IgA肾病大鼠血清醛固酮及肾内小动脉病变的影响[J].陕西中医,2022,(4):421-426.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.003]
　WANG Ruiqi,ZHANG Xiaodong,TIAN Yun.Effects of Shenfukang Ⅱ capsule on aldosterone and intrarenal arterioles in IgAN rats[J].,2022,(4):421-426.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.003]
点击复制

肾复康Ⅱ号胶囊对IgA肾病大鼠血清醛固酮及肾内小动脉病变的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年4期
页码:
421-426
栏目:
基础研究
出版日期:
2022-04-05

文章信息/Info

Title:
Effects of Shenfukang Ⅱ capsule on aldosterone and intrarenal arterioles in IgAN rats
作者:
王睿琪1; 张晓东2; 田 耘3
(1.陕西中医药大学,陕西 咸阳712046; 2.宝鸡市第三人民医院肾内科,陕西 宝鸡 721000; 3.陕西省中医医院肾病一科,陕西 西安710003)
Author(s):
WANG Ruiqi; ZHANG Xiaodong; TIAN Yun
(Shaanxi University of Chinese Medicine,Xianyang 712046,China)
关键词:
IgA肾病;  肾内小动脉病变;  醛固酮;  人基质金属蛋白酶-9;  增殖细胞核抗原;  肾复康Ⅱ号胶囊
Keywords:
IgA nephropathy;  Pathological mechanism of intrarenal arterioles;  Aldosterone;  Human matrix metalloproteinase-9;  Proliferating cell nuclear antigen;  Shenfukang Ⅱ capsule
分类号:
R 692
DOI:
DOI:10.3969/j.issn.1000-7369.2022.04.003
文献标志码:
A
摘要:
目的:观察肾复康Ⅱ号胶囊对IgA肾病(IgAN)肾内小动脉病变大鼠醛固酮诱导的血管内皮细胞生长因子(VEGF)、增殖细胞核抗原(PCNA)、人基质金属蛋白酶-9(MMP-9)的表达,探讨肾复康Ⅱ号胶囊对IgAN小动脉病变的防治机制。方法:将70只健康雄性SD大鼠分为空白组、模型组、治疗组(肾复康组)、中药对照组(黄葵组)、西药对照组(螺内酯组),采用0.9%氯化钠水溶液灌胃+皮下注射CCl4+静脉注射脂多糖建造IgAN大鼠模型。空白组、模型组给予0.9%氯化钠水溶液灌胃,余组给予相应药物灌胃,给药后4、8、12周时点检测大鼠24 h尿蛋白定量,12周时点检测大鼠肾脏指标、血清醛固酮、AngⅡ,免疫组织化学Envision System二步法检测大鼠小动脉区域VEGF、MMP-9、PCNA,检测IgAN造模大鼠肾组织内膜/血管外径值、中膜/血管外径值、管壁/血管外径值。结果:与同时点模型组相比,三组24 h U-TP均下降,血肌酐及尿素氮水平降低,血清醛固酮肾复康组与两对照组比较差异明显。内膜及管壁/血管外径值明显减小(P<0.05),管壁增厚与VEGF、PCNA、MMP-9的表达中度相关(0.5
Abstract:
Objective:To observe the expression of Shenfukang Ⅱ capsule on aldosterone-induced vascular endothelial cell growth factor(VEGF),proliferating cell nuclear antigen(PCNA)and human matrix metalloproteinase-9(MMP-9)in rats with IgA nephropathy(IgAN)intrarenal arteriopathy,and to explore the effect of Shenfukang Ⅱ capsule on IgAN arteriole disease prevention mechanism.Methods:70 healthy male SD rats were divided into blank group,model group,treatment group(Shenfukang group),traditional Chinese medicine control group(Huangkui group),western medicine control group(spironolactone group),and normal saline gavage + Subcutaneous injection of CCL4+ intravenous injection of lipopolysaccharide to build IgAN rat model.The blank group and the model group were given normal saline by gavage,and the remaining groups were given the corresponding drugs by gavage.The 24 h urine protein was measured at 4,8 and 12 weeks after the administration,and the rat's kidney indexes were measured at 12 weeks.Serum aldosterone,AngⅡ,immunohistochemical Envision System two-step method to detect VEGF,MMP-9,PCNA in rat arterioles,and IgAN production model rat kidney tissue intima/vascular outer diameter value,media/vascular outer diameter value,tube wall/vascular outer diameter value.Results:Compared with the simultaneous point model group,the 24-hour U-TP of the three groups decreased,and the blood creatinine and urea nitrogen levels decreased.The serum aldosterone Shenfukang group was significantly different from the two control groups.Intima and vessel wall/vascular outer diameter values were significantly reduced(P<0.05),vessel wall thickening was moderately correlated with the expression of VEGF,PCNA,and MMP-9(0.5

参考文献/References:

[1] 谌贻璞.肾内科学[M].北京:人民卫生出版社,2015:13-14.
[2] Liu ZH.Long-term renal survival and related risk factors in patients with IgA nephropathy:Results from a cohort of 1155 cases in a Chinese adult population [J].Nephrology Dialysis Transplantation,2012,27(4):1479.
[3] 华军谊,何煜舟,蒋旭宏,等.川芎嗪抑制血管平滑肌细胞增殖及胶原合成的作用机制研究[J].中国中西医结合杂志,2013,33(9):1226-1231.
[4] 马春阳,万小平,杨 堃,等.Rho激酶在醛固酮诱导的血管平滑肌细胞增殖中的作用[J].中国临床药理学杂志,2016,32(1):39-41.
[5] 张晓凤,田 耘,程小红,等.肾复康Ⅱ号对MSCs旁分泌作用的实验研究[J].西部中医药,2018,31(10):4-7.
[6] 程小红,张晓凤,毛加荣,等.益肾散结复方对单侧输尿管结扎和5/6肾切除模型大鼠肾脏病理改变及肾功能的影响[J].陕西中医药大学学报,2018,41(1):93-96.
[7] 程小红,邢 斌,刘建红,等.益肾散结法对大鼠肾脏间质纤维化组织TGF-β1和PAI-1表达的影响[J].陕西中医,2018,39(2):143-145.
[8] 费 梅,熊佩华,周丽霞,等.两种IgA肾病大鼠模型的比较[J].江苏医药,2016,42(13):1435-1438.
[9] 田 耘,程小红,于小勇,等.肾血安对IgA肾病大鼠凝血纤溶系统的影响[J].陕西中医,2013,34(12):1674-1676.
[10] 孔 军,董 葆,王 梅.IgA肾病肾内小动脉病变特点及其可能发生机制[J].中国血液净化,2011,10(6):335-339.
[11] 李增艳,王彩丽.IgA肾病的动脉病变[J].中国医药指南,2013,11(7):69-71.
[12] Taiko K,Hideki TMD, Kang DD.Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy[J].Human Pathology,2015,10(13):135-144.
[13] 华军谊,何煜舟,蒋旭宏,等.川芎嗪抑制血管平滑肌细胞增殖及胶原合成的作用机制研究[J].中国中西医结合杂志,2013,33(9):1226-1231.
[14] 朱 丹,胡大春.microRNA在原发性高血压病理机制中的研究进展[J].医学综述,2020,26(20):3992-3998.
[15] Zhang JX,Zhou SL,Xia ZK,et al.595 nm pulsed dye laser combined with fractional CO2 laser reduces hypertrophic scar through down-regulating TGFβ1 and PCNA[J].Lasers in Medical Science,2021,36(8):1625-1632.
[16] 温晓洲,孙爱华,李广平,等.基质金属蛋白酶9的研究进展[J].岭南急诊医学杂志,2021,26(2):216-218.
[17] 陈瑞娟,吴 坚,田 芳,等.参附注射液对氧化应激血管内皮损伤及相关信号转导通路的影响[J].南京中医药大学学报 2021,37(4):529-534.
[18] Ruiz-Ortega M,Ruperez M,Esteban V,et al.Molecular mechanisms of angiotensin Ⅱ induced vascular injury[J].Curr Hypertens Rep,2003,5(1):73-79.
[19] 徐 薇,于小勇,毛加荣,等.慢性肾小管间质疾病的病理改变临床特点与鉴别诊断[J].中国中西医结合肾病杂志,2018,19(7):46-47.
[20] 程小红,于小勇,毛加荣.IgA肾病的病理改变与中医微观辨证[J].中国中西医结合肾病杂志,2014,15(2):185-186.
[21] 权浩浩,程小红,杜 霞,等.基于整合药理学探讨肾复康Ⅱ号胶囊治疗肾间质纤维化作用机制[J].陕西中医,2020,41(12):1822-1826.

相似文献/References:

[1]李二敏.加味当归补血汤对 IgA 肾病患者抑制细胞因子聚集及延缓肾脏纤维化的保护作用*[J].陕西中医,2019,(1):64.
[2]张靖华,梁 冰,吴秋杰,等.固肾宁血合剂治疗IgA肾病疗效及对患者血管内皮生长因子及转移生长因子-β1表达的影响*[J].陕西中医,2019,(6):757.
[3]黄 敏,杜珍芳,张红艳.IgA肾病从风、湿、瘀论治探讨[J].陕西中医,2022,(4):499.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.022]
[4]徐梅秀,李丽琦.《伤寒论》六经辨证在IgA肾病诊治中的指导价值[J].陕西中医,2023,(5):615.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.017]
　XU Meixiu,LI Liqi.The guiding value of six meridians differentiation in diagnosis and treatment of IgA nephropathy in treatise on febrile diseases[J].,2023,(4):615.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.017]
[5]毛加荣,刘 稳,芮宏亮,等.IgA肾病107例中医证型与临床、病理及实验室检查相关性分析[J].陕西中医,2023,(9):1231.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.017]
　MAO Jiarong,LIU Wen,RUI Hongliang,et al.Correlation analysis of TCM syndrome types with clinical,pathological and laboratory examination in 107 cases of IgA nephropathy patients[J].,2023,(4):1231.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.017]
[6]向广生,唐晨思,路博宇,等.凉血散瘀汤结合常规西药治疗IgA肾病疗效及对患者血液流变学、炎性细胞因子水平的影响[J].陕西中医,2024,(1):63.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.014]
　XIANG Guangsheng,TANG Chensi,LU Boyu,et al.Effects of Liangxue Sanyu decoction combined with conventional western medicine on hemorheology and inflammatory cytokine levels in patients with IgA nephropathy[J].,2024,(4):63.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.014]
[7]艾山江·艾合买提,田 耘.从湿热论治IgA肾病[J].陕西中医,2024,(3):380.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.021]
[8]唐晨思,向广生,张翠娜,等.健脾益肾通络汤对IgA肾病患者肾功能、炎症因子的影响[J].陕西中医,2024,(11):1499.[doi:DOI:10.3969/j.issn.1000-7369.2024.11.012]
　TANG Chensi,XIANG Guangsheng,ZHANG Cuina,et al.Impact of Jianpi Yishen Tongluo decoction on renal function and inflammatory factors in patients with IgA nephropathy[J].,2024,(4):1499.[doi:DOI:10.3969/j.issn.1000-7369.2024.11.012]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81774123); 陕西省重点研发计划项目(2018ZDXM-SF-011)
更新日期/Last Update: 2022-04-08